GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (STU:L74) » Definitions » Price-to-Funds-From-Operations

WuXi XDC Cayman (STU:L74) Price-to-Funds-From-Operations : (As of Dec. 11, 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


WuXi XDC Cayman Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.